Keith Crandell
Director at 908 Devices; Director at Twist Bioscience; Director at Quanterix. Based in Chicago, Illinois.
- Rank
- 7571st of 14,644
- Companies held
- 3
- Largest holding
- TWST, 94.8% of total
- Latest SEC filing
- Jun 10, 2026
- Listed but not counted
- $53.8M
What the $12.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Twist Bioscience TWST Common Stock | Through Keith L. Crandell Trust | 76,047 | $111.62 | $8.5M | 69.6% | Form 4, Feb 5, 2026 |
| Twist Bioscience TWST Common Stock | Directly | 27,571 | $111.62 | $3.1M | 25.2% | Form 4, Feb 5, 2026 |
| 908 Devices MASS Common Stock | Directly | 39,374 | $9.37 | $369K | 3.0% | Form 4, Jun 10, 2026 |
| Quanterix QTRX Common Stock | Directly | 131,236 | $2.03 | $266K | 2.2% | Form 4, Apr 3, 2023 |
Share counts are the amounts Keith Crandell reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Keith Crandell's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| 908 Devices MASS Common Stock | Through ARCH Venture Fund VII, L.P. Held by a company or fund the insider manages | 5,725,045 | $9.37 | $53.6M | — | Form 4, Jun 10, 2026 |
| Boundless Bio BOLD Common Stock | Through ARCH Venture Fund IX Overage, L.P. Held by a company or fund the insider manages | 41,025 | $2.38 | $98K | — | Form 3, Mar 27, 2024 |
| Boundless Bio BOLD Common Stock | Through ARCH Venture Fund IX, L.P. Held by a company or fund the insider manages | 27,349 | $2.38 | $65K | — | Form 3, Mar 27, 2024 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7568 | Ravi Mohan Valiyaveettil Chief Technology Officer, Credit Acceptance. Southfield, MI | $12.2M |
| 7569 | Edwin A. Sheridan Director, Everforth. Glen Allen, VA | $12.2M |
| 7570 | Jay D. Martin Chief Financial Officer, Credit Acceptance. Southfield, MI | $12.2M |
| 7571 | Keith Crandell Director, 908 Devices. Chicago, IL | $12.2M |
| 7572 | Sean M. Dell'Orto EVP, CFO & Treasurer, Park Hotels & Resorts. Tysons, VA | $12.2M |
| 7573 | Jack E. Engelkes Director, Home BancShares. Conway, AR | $12.2M |
| 7574 | David A. Westerlund Director, Xcel Energy. Minneapolis, MN | $12.2M |
Other 908 Devices insiders
All MASS insiders- Kevin J. Knopp$10.3MPresident and CEO. #8605 overall
- Christopher D. Brown$7.8MDirector. #10580 overall
- E. Kevin Hrusovsky$4.6MDirector. #12061 overall
- Anthony Hunt$414KDirector. #6240 overall
- Jeffrey P. George$251KDirector. #10703 overall
Questions
How much stock does Keith Crandell own?
Keith Crandell holds $12,201,185 in listed stock based on SEC filings and current prices, mostly Twist Bioscience (TWST). That ranks 7571st on the Stock Rich List.
Is this Keith Crandell's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with Robert Nelsen, SEC filer 1219043, SEC filer 1229592.